Add-on Study of Pentoxifylline in Cutaneous Leishmaniasis
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether adding pentoxifylline to treatment of
American cutaneous leishmaniasis with meglumine antimoniate increases the rate and speed of
clinical response without diminishing safety, and to identify immune correlates of the
healing response.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Centro Internacional de Entrenamiento e Investigaciones Médicas